Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 18, 2013, Pages 2772-2780

  Chan, Dessy ^a   Tsoi, Miriam Yuen Tung ^a   Liu, Christina Di ^a   Chan, Sau Hing ^a   Law, Simon Ying Kit ^b   Chan, Kwok Wah ^b   Chan, Yuen Piu ^b   Gopalan, Vinod ^c   Lam, Alfred King Yin ^c   Tang, Johnny Cheuk On ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Calpain 10; Esophageal squamous cell carcinoma; Oncogene; RNA interference; Tissue microarray

Indexed keywords

CALPAIN 10; TRINUCLEOTIDE; TRINUCLEOTIDE REPEAT CONTAINING 6C; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FLOW CYTOMETRY; GAEC1 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; ONCOGENE; OVERALL SURVIVAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE MICROARRAY; UPREGULATION;

EID: 84877808476     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i18.2772     Document Type: Article

References (42)

1. Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol 2007; 19: 171-176. [PMID: 17273005 DOI: 10.1097/ MEG.0b013e32800ff77a]
2. Lam AK. Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 2000; 33: 71-90. [PMID: 10737369 DOI: 10.1016/s1040-8428(99)00054-2]
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. [PMID: 21296855 DOI: 10.3322/caac.20107]
4. Ghadimi MR, Rasouli M, Mahmoodi M, Mohammad K. Prognostic factors for the survival of patients with esophageal cancer in Northern Iran. J Res Med Sci 2011; 16: 1261-1272. [PMID: 22973319]
5. Bellini MF, Silva AE, Varella-Garcia M. Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques. Genet Mol Biol 2010; 33: 205-213. [PMID: 21637470 DOI: 10.1590/s1415-47572010005000028]
6. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H, Faried A. Genetic alterations in esophageal cancer. Surg Today 2005; 35: 7-18. [PMID: 15622457 DOI: 10.1007/s00595-004-2885-3]
7. Tang JC, Lam KY, Law S, Wong J, Srivastava G. Detection of genetic alterations in esophageal squamous cell carcinomas and adjacent normal epithelia by comparative DNA fingerprinting using inter-simple sequence repeat PCR. Clin Cancer Res 2001; 7: 1539-1545. [PMID: 11410488]
8. Touchman JW, Bouffard GG, Weintraub LA, Idol JR, Wang L, Robbins CM, Nussbaum JC, Lovett M, Green ED. 2006 expressed-sequence tags derived from human chromosome 7-enriched cDNA libraries. Genome Res 1997; 7: 281-292. [PMID: 9074931 DOI: 10.1101/gr.7.3.281]
9. Glöckner G, Scherer S, Schattevoy R, Boright A, Weber J, Tsui LC, Rosenthal A. Large-scale sequencing of two regions in human chromosome 7q22: analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci reveals 17 genes. Genome Res 1998; 8: 1060-1073. [PMID: 9799793]
10. Schaefer IM, Enders C, Polten A, Haller F, Frölich AM, Cameron S, Schüler P, Schweiger P, Gunawan B, Beham A, Füzesi L. Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol 2011; 135: 579-586. [PMID: 21411780 DOI: 10.1309/ajcpz1o7uuuispnr]
11. Pinto AE, Roque L, Rodrigues R, André S, Soares J. Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation. J Clin Pathol 2006; 59: 367-372. [PMID: 16461572 DOI: 10.1136/jcp.2005.027722]
12. Chang MC, Chang YT, Tien YW, Sun CT, Wu MS, Lin JT. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol Rep 2005; 14: 867-872. [PMID: 16142344]
13. Baudis M. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer 2007; 7: 226. [PMID: 18088415 DOI: 10.1186/1471-2407-7-226]
14. Miyata T, Yonekura K, Utsunomiya A, Kanekura T, Nakamura S, Seto M. Cutaneous type adult T-cell leukemia/lymphoma is a characteristic subtype and includes erythema/ papule and nodule/tumor subgroups. Int J Cancer 2010; 126: 1521-1528. [PMID: 19739121 DOI: 10.1002/ijc.24874]
15. Law FB, Chen YW, Wong KY, Ying J, Tao Q, Langford C, Lee PY, Law S, Cheung RW, Chui CH, Tsao SW, Lam KY, Wong J, Srivastava G, Tang JC. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene 2007; 26: 5877-5888. [PMID: 17384685 DOI: 10.1038/sj.onc.1210390]
16. Gopalan V, Smith RA, Nassiri MR, Yasuda K, Salajegheh A, Kim SY, Ho YH, Weinstein S, Tang JC, Lam AK. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Hum Pathol 2010; 41: 1009-1015. [PMID: 20236690 DOI: 10.1016/ j.humpath.2009.11.014]
17. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992; 69: 277-284. [PMID: 1728357 DOI: 10.1002/1097-0142(19920115)69]
18. Deng W, Tsao SW, Guan XY, Lucas JN, Si HX, Leung CS, Mak P, Wang LD, Cheung AL. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: wholegenome evidence from multiple cell lines. Oncogene 2004; 23: 9090-9101. [PMID: 15489894 DOI: 10.1038/sj.onc.1208119]
19. Yuen HF, Chan YP, Chan KK, Chu YY, Wong ML, Law SY, Srivastava G, Wong YC, Wang X, Chan KW. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer 2007; 97: 1409-1415. [PMID: 18000500 DOI: 10.1038/sj.bjc.6604035]
20. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002; 40: 2-11. [PMID: 11903593 DOI: 10.1046/j.1365-2559.2002.01343.x]
21. Derenzini M. The AgNORs. Micron 2000; 31: 117-120. [PMID: 10588056 DOI: 10.1016/s0968-4328(99)00067-0]
22. Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/ shRNA therapeutics in clinical trials. Biotechnol J 2011; 6: 1130-1146. [PMID: 21744502 DOI: 10.1002/biot.201100054]
23. Qian H, Lu N, Xue L, Liang X, Zhang X, Fu M, Xie Y, Zhan Q, Liu Z, Lin C. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis 2005; 22: 653-662. [PMID: 16703414 DOI: 10.1007/s10585-006-9005-2]
24. Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, Mizuno A, Nemoto TK. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010; 39: 61-67. [PMID: 19913389 DOI: 10.1016/j.ijom.2009.10.003]
25. Likui W, Hong W, Shuwen Z, Yuangang Y, Yan W. The potential of osteopontin as a therapeutic target for human colorectal cancer. J Gastrointest Surg 2011; 15: 652-659. [PMID: 21318445 DOI: 10.1007/s11605-011-1445-6]
26. Hu Y, Shen Y, Ji B, Wang L, Zhang Z, Zhang Y. Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT. Eur J Pharm Sci 2011; 42: 387-391. [PMID: 21238587]
27. Vázquez-Vega S, Contreras-Paredes A, Lizano-Soberón M, Amador-Molina A, García-Carrancá A, Sánchez-Suárez LP, Benítez-Bribiesca L. [RNA interference (RNAi) and its therapeutic potential in cancer]. Rev Invest Clin 2010; 62: 81-90. [PMID: 20415062]
28. Kar P, Samanta K, Shaikh S, Chowdhury A, Chakraborti T, Chakraborti S. Mitochondrial calpain system: an overview. Arch Biochem Biophys 2010; 495: 1-7. [PMID: 20035707 DOI: 10.1016/j.abb.2009.12.020]
29. Brown AE, Yeaman SJ, Walker M. Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells. Mol Genet Metab 2007; 91: 318-324. [PMID: 17572128 DOI: 10.1016/j.ymgme.2007.05.001]
30. Horikawa Y. Calpain-10 (NIDDM1) as a Susceptibility Gene for Common Type 2 Diabetes. Endocr J 2006; 53: 567-576. [PMID: 16873988 DOI: 10.1507/endocrj.KR-70]
31. Moreno-Luna R, Abrante A, Esteban F, González-Moles MA, Delgado-Rodríguez M, Sáez ME, González-Pérez A, Ramírez-Lorca R, Real LM, Ruiz A. Calpain 10 gene and laryngeal cancer: a survival analysis. Head Neck 2011; 33: 72-76. [PMID: 20848425 DOI: 10.1002/hed.21404]
32. Frances CP, Conde MC, Saez ME, Diez SF, Rey CM, Ramírez- Armengol JA, Pascual MH, Gonzalez-Perez A, Torres PP, Real LM, Serrano-Rios M, López JL, Ruiz A, Royo JL. Identi fication of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility. J Gastroenterol Hepatol 2007; 22: 2298-2302. [PMID: 17559371 DOI: 10.1111/ j.1440-1746.2007.04843.x]
33. Fong PY, Fesinmeyer MD, White E, Farin FM, Srinouanprachanh S, Afsharinejad Z, Mandelson MT, Brentnall TA, Barnett MJ, Goodman GE, Austin MA. Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers. J Gastrointest Cancer 2010; 41: 203-208. [PMID: 20178008 DOI: 10.1007/s12029-010-9130-7]
34. Tsunoda S, Nakamura T, Sakurai H, Saiki I. Fibroblast growth factor-2-induced host stroma reaction during initial tumor growth promotes progression of mouse melanoma via vascular endothelial growth factor A-dependent neovascularization. Cancer Sci 2007; 98: 541-548. [PMID: 17359289 DOI: 10.1111/j.1349-7006.2007.00432.x]
35. Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM, Lobo-Ruppert SM. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther 2005; 4: 1401-1408. [PMID: 16357510]
36. Popple A, Durrant LG, Spendlove I, Rolland P, Scott IV, Deen S, Ramage JM. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer 2012; 106: 1306-1313. [PMID: 22415233 DOI: 10.1038/ bjc.2012.49]
37. Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, Jia WH. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. J Surg Oncol 2011; 104: 617-622. [PMID: 21744352 DOI: 10.1002/ jso.22018]
38. Kim MS, Oh JE, Kim YR, Park SW, Kang MR, Kim SS, Ahn CH, Yoo NJ, Lee SH. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol 2010; 221: 139-146. [PMID: 20198652 DOI: 10.1002/path.2683]
39. Morita S, Matsumoto Y, Okuyama S, Ono K, Kitamura Y, Tomori A, Oyama T, Amano Y, Kinoshita Y, Chiba T, Marusawa H. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett' s oesophageal adenocarcinoma. Carcinogenesis 2011; 32: 1706-1712. [PMID: 21890457 DOI: 10.1093/carcin/bgr194]
40. Shinmura K, Igarashi H, Goto M, Tao H, Yamada H, Matsuura S, Tajima M, Matsuda T, Yamane A, Funai K, Tanahashi M, Niwa H, Ogawa H, Sugimura H. Aberrant expression and mutation-inducing activity of AID in human lung cancer. Ann Surg Oncol 2011; 18: 2084-2092. [PMID: 21290192 DOI: 10.1245/s10434-011-1568-8]
41. Endo Y, Marusawa H, Chiba T. Involvement of activationinduced cytidine deaminase in the development of colitisassociated colorectal cancers. J Gastroenterol 2011; 46 (Suppl 1): 6-10. [PMID: 20878190 DOI: 10.1007/s00535-010-0326-1]
42. Goto A, Hirahashi M, Osada M, Nakamura K, Yao T, Tsuneyoshi M, Takayanagi R, Oda Y. Aberrant activationinduced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch 2011; 458: 717-724. [PMID: 21538122 DOI: 10.1007/s00428-011-1086-x]